MedTrace Logo

Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

NCT01448915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 828

Last updated 2022-02-21

No results posted yet for this study

Summary

The principal goal of this research project is to evaluate the natural history of HCV and liver disease and its treatment in HIV-infected persons who use drugs. Research procedures will focus on determining liver disease prevalence and severity within this population. This is an observational study without study specific interventions.

Conditions

  • HIV Infection
  • Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • Mark S. Sulkowski, MD · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01448915 on ClinicalTrials.gov